WT1 aberrant methylation may lead to a reduction or absence of WT1 expression, which results in the overexpression of the insulin-like growth factor I receptor (IGF 1R) and insulin-like growth factor II (IGF II), thereby promoting breast cancer process [10–12]. The gene discussed is IGF2; the disease is breast cancer.